DR.INFO vs OpenEvidence (2026): CE-Certified European Evidence AI vs US Clinical AI Giant (Withdrew from EU/UK)
At a Glance
Who is it for?
DR.INFO (Synduct GmbH):European clinicians and students
OpenEvidence:US physicians only (withdrew from EU/UK)
Why choose DR.INFO (Synduct GmbH)?
- **Available in Europe** — live and accessible
- **CE-certified medical device**
- Drug databases with dosing and interactions
- 12+ European language support
- Visual abstracts
- API offering
- GDPR-compliant; EU-hosted
- Free tier + Pro (€9.92/month)
Why choose OpenEvidence?
- **$12B valuation; $700M+ funding**
- **NEJM, JAMA, Cochrane, NCCN content partnerships**
- **Epic EHR embedded** (Mount Sinai, Sutter Health)
- **$100M ARR**
- **757,000+ clinician users**
- Proprietary models trained on peer-reviewed literature
Feature Comparison
| Capability | DR.INFO (Synduct GmbH) | OpenEvidence |
|---|---|---|
| European Availability | **Available in EU/UK** | **Withdrew from EU/UK** (April 2026) |
| Regulatory Status | **CE-certified medical device** | US-focused; cited EU AI Act uncertainty |
| Content Partnerships | PubMed, FDA, clinical guidelines | **NEJM, JAMA, Cochrane, NCCN, ACC, ADA, AAFP** |
| E H R Integration | Organisation tier offers EHR/EMR integration | **Epic-embedded** |
| Drug Content | **Dedicated drug database** | Drug info within broader evidence search |
| Language Support | **12+ European languages** | English primarily |
| Pricing | Free tier; Pro €9.92/month | Free for verified US HCPs (pharma ad-funded) |
In-Depth Analysis
Overview
OpenEvidence proved the category ($12B, $100M ARR, 40%+ daily physician use in the US) then withdrew from Europe. DR.INFO is one of the European-native tools positioned to fill that gap — CE-certified, with drug databases, multilingual support, and an API.
For UK clinicians wanting MHRA-registered guideline retrieval plus 15+ exam Q-banks and 80+ calculators, iatroX occupies the UK-guideline-first lane.
Public information as of 3 May 2026. Trademarks belong to their owners.
Looking for a faster way?
While DR.INFO (Synduct GmbH) and OpenEvidence are powerful tools, iatroX offers a free, AI-driven alternative focused specifically on rapid UK guideline retrieval and exam prep.
Use-Cases
European Clinician Wanting Evidence AI
When to choose DR.INFO (Synduct GmbH)
- **Winner.** Live, CE-certified, multilingual, and available in Europe.
When to choose OpenEvidence
- No longer available in EU/UK.
US Physician
When to choose DR.INFO (Synduct GmbH)
- Available but not optimised for US workflows.
When to choose OpenEvidence
- **Winner.** Dominant US platform with Epic integration.
OpenEvidence Alternative in Europe
When to choose DR.INFO (Synduct GmbH)
- Strong option — CE-certified, drug databases, multilingual.
When to choose OpenEvidence
- N/A — withdrew.